Work

Phase 2 Study of Intratumoral Vidutolimod With Intravenous Cemiplimab in Patients With Locally Advanced or Metastatic Merkel Cell Carcinoma (CMP-001- 009)

Year: 2022

Type: article

Study design: Clinical Trial

Source: Journal of Investigative Dermatology

DOI: 10.1016/j.jid.2022.08.006

Authors: Shailender Bhatia, John R. Hyngstrom, Alexandra Ikeguchi, Sajeve S. Thomas, Ann W. Silk, Dmitri Bobilev, Luping Zhao, James E. Wooldridge, Arthur M. Krieg, Diwakar Davar

Institutions: University of Washington Medical Center, University of Utah, Huntsman Cancer Institute, OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Orlando Health, Dana-Farber Cancer Institute, University of Pittsburgh Medical Center

Language: English

Topic: Polyomavirus and related diseases

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4296558398

FWCI:

Cites:

Cited by:

Related to: 10